IP Library Assignment 014988/0727
Patent Assignment
Reel/Frame 014988/0727

Assignment of Assignor's Interest

Recorded: 2004-02-12 Pages: 2
Assignors
KOSITPRAPA, UNCHALEE
Executed: 2004-02-05
GOLDFARB, ROBERT
Executed: 2004-02-05
CARDINAL, JOHN
Executed: 2004-02-09
NANGIA, AVINASH
Executed: 2004-02-10
Assignee
ANDRX LABS LLC
4955 ORANGE DRIVE, DAVIE, FLORIDA, 33314
Covered Property (1)
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 7,959,946 →
Application: 10/777,542 →
Publication: US 2004/0161462
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Second Supplemental Security Agreement Jan 25, 2005
From: ANDRX LABS, LLC; ANDA, INC.; ANDRX PHARMACEUTICALS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 016180/0093 →
Release of Security Interest Oct 26, 2005
From: BANK OF AMERICA, N.A., AS AGENT
To: ANDA, INC.; ANDRX CORPORATION; ANDRX LABS, LLC; ANDRX LABORATORIES, INC.
Reel/Frame 016674/0980 →
Assignment of Assignor's Interest Mar 18, 2009
From: ANDRX LABS, LLC
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 022413/0374 →
Change of Name Jul 5, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 030741/0511 →
Assignment of Assignor's Interest Jan 20, 2017
From: ALLERGAN FINANCE, LLC
To: ACTAVIS HOLDCO US, INC.
Reel/Frame 041449/0799 →
Change of Name Jan 20, 2017
From: ACTAVIS, INC.
To: ALLERGAN FINANCE, LLC
Reel/Frame 041459/0788 →